Greg Parekh

Greg Parekh is an accomplished executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Chairman of the Board for Alveus Therapeutics and Butterfly Medical, as well as a member of the Board of Directors for American Injectables, Greg is also the Founder and Managing Partner of New Rhein Healthcare Investors, a venture capital firm. Previous roles include Chairman of the Board for Chase Pharmaceuticals and CEO of Biocartis, where significant funding was raised and strategic direction was established in oncology. Greg has a robust background in mergers and acquisitions from their tenure at Novartis and Deutsche Bank, where over 20 transactions totaling $70 billion were executed. Educational credentials include a PhD in Economics from Northwestern University’s Kellogg School of Management and a BA in Economics and Political Science from the University of Rochester.